Drug
Deferoxamine clinical trials
Also written Desferal and Desferrioxamine.
- studies test it
- 35
- open now
- 6
- in phase 3
- 3
- first study started
- 2000
Keep track of what changes. Save the Deferoxamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Other names
Studies by the year they started
34 studies that test it; most in 2008 (5)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 2 |
| 2008 | 5 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 7
- Phase 2
- 22
- Phase 3
- 3
- Phase 4
- 4
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 27
Novartis Pharmaceuticals (4) · Brigham and Women's Hospital (3) · Beth Israel Deaconess Medical Center (3) · Lipomed (2) · Karolinska University Hospital (2) · RESnTEC, Institute of Research (1) · Germans Trias i Pujol Hospital (1) · ApoPharma (1)
Often tested with
Tested in the same studies.
Deferasirox (6) · Deferiprone (5) · Acetylcysteine (1) · Colchicine (1) · Xingnaojing (1) · Blood Transfusion (1)
Studies
Open first, then newest update. How each study uses Deferoxamine is read from its arms, and is right about nine times in ten.
Testing it · 35
- Early Screening and Treatment of Heart Complication in Sickle Cell DiseaseRecruitingPhase 2Inova Health Care ServicesNCT07023666Written as Deferoxamine
- A Study of Deferoxamine (DFO) in People With Leptomeningeal MetastasisRecruitingPhase 1Memorial Sloan Kettering Cancer CenterNCT05184816Written as Deferoxamine (DFO)
- The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBALRecruitingPhase 3The George InstituteNCT06763055Written as Deferoxamine Mesylate
- Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)RecruitingPhase 2Aditya S. Pandey, MDNCT04566991Written as Deferoxamine
- Synergistic Minimally Invasive Surgery and Deferoxamine in ICHNot yet recruitingPhase 2/3University of Illinois at ChicagoNCT07162363Written as Deferoxamine
- Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot UlcersNot yet recruitingPhase 2Karolinska University HospitalNCT03137966Written as Deferoxamine
- Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney InjuryCompletedPhase 2Brigham and Women's HospitalNCT04633889Written as Deferoxamine
- Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast CancerTerminatedPhase 2Sun Yat-sen UniversityNCT05300958Written as Deferoxamine Plus Chemotherapy
- Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron OverloadCompletedNot applicableRESnTEC, Institute of ResearchNCT06468423Written as Deferoxamine (DFO)
- Deferoxamine in Aneurysmal Subarachnoid Hemorrhage TrialStatus unknownPhase 1/2Radboud University Medical CenterNCT02875262Written as Deferoxamine
- Thrombolysis and Deferoxamine in Middle Cerebral Artery OcclusionCompletedPhase 2Germans Trias i Pujol HospitalNCT00777140Written as Deferoxamine
- Desferal Administration to Improve the Impaired Reaction to Hypoxia in DiabetesStatus unknownPhase 2Karolinska University HospitalNCT03085771Written as desferal
- Deferoxamine for Sickle Cell Chronic Leg Ulcer TreatmentWithdrawnPhase 1/2TauTona GroupNCT04058197Written as Deferoxamine Product
- Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron OverloadCompletedPhase 2Novartis PharmaceuticalsNCT01254227Written as Deferasirox and Deferoxamine
- Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 InfectionStatus unknownPhase 4Hesham Al-InanyNCT04389801Written as Desferal 500 MG Injection
- Application of Desferal to Treat COVID-19Status unknownPhase 1/2Kermanshah University of Medical SciencesNCT04333550Written as Deferoxamine
- Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron OverloadTerminatedPhase 2Novartis PharmaceuticalsNCT01459718Written as Deferoxamine (DFO)
- High-Dose Deferoxamine in Intracerebral HemorrhageTerminatedPhase 2Beth Israel Deaconess Medical CenterNCT01662895Written as Deferoxamine
- Intracerebral Hemorrhage Deferoxamine Trial - iDEF TtrialCompletedPhase 2Beth Israel Deaconess Medical CenterNCT02175225Written as Deferoxamine Mesylate
- Dose Finding and Safety Study of Deferoxamine in Patients With Brain HemorrhageCompletedPhase 1Beth Israel Deaconess Medical CenterNCT00598572Written as Deferoxamine Mesylate
See all 35 studies that test Deferoxamine →
Given in every arm · 3 — Deferoxamine is usual care beside what is tested
- Pilot Study for Patients With Poor Response to DeferasiroxCompletedPhase 4Boston Children's HospitalNCT00749515Written as Deferoxamine
- Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major ThalassemiaCompletedPhase 2/3Beni-Suef UniversityNCT04292314Written as Deferoxamine
- Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac DiseasesTerminatedPhase 2Carelon ResearchNCT00115349Written as Deferoxamine
As the comparator · 6 — what is tested is compared with Deferoxamine
- Evaluate the Efficacy and Safety of Irochel for the Management of Iron Overload in Thalassemia Patients in Comparison With DeferoxamineCompletedPhase 3Hamdard UniversityNCT07782931Written as Deferoxamine
- Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other AnemiasTerminatedPhase 4ApoPharmaNCT02041299Written as Deferoxamine
- Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in TunisiaStatus unknownPhase 3Abderrahmane Mami HospitalNCT04361032Written as Deferoxamine
- Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron OverloadCompletedPhase 2Novartis PharmaceuticalsNCT00600938Written as Core Study: Deferoxamine
- Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood TransfusionsCompletedPhase 3Novartis PharmaceuticalsNCT00061750Written as deferoxamine
- Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron OverloadCompletedNot applicableHormozgan University of Medical SciencesNCT01369719Written as Desferal
Codes
What other systems call Deferoxamine · ClinicalTrials.gg INT007304
- MeSH (NLM) D003676DeferoxamineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) J06Y7MXW4DDEFEROXAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 3131Confirmed FDA, Wikidata
- Wikidata Q419618deferoxamineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C416DeferoxamineOne source FDA
- DrugBank DB00746One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003676 | Deferoxamine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | J06Y7MXW4D | DEFEROXAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3131 | — | Confirmed FDA, Wikidata |
| Wikidata | Q419618 | deferoxamine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C416 | Deferoxamine | One source FDA |
| DrugBank | DB00746 | — | One source Wikidata |
Also registered as deferoxamine mesylate (UNII V9TKO7EO6K · RxNorm 3132).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.